Development and Characterization of Biodegradable Chitosan Nanoparticles Loaded with Lovastatin using Factorial Design

被引:0
作者
Shinde, Anilkumar J. [1 ]
More, Harinath N. [1 ]
机构
[1] Bharati Vidyapeeth Coll Pharm, Dept Pharmaceut, Kolhapur, Maharashtra, India
来源
LATIN AMERICAN JOURNAL OF PHARMACY | 2011年 / 30卷 / 09期
关键词
Chitosan; Factorial design; Ionotropic gelation; Lovastatin; Oral drug delivery; Sustained release; CONTROLLED-RELEASE; IN-VITRO; COMPLEX; TRIPOLYPHOSPHATE; BEADS; DIET;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The objective of the present work was to formulate chitosan nanoparticles as carriers for the lovastatin, since this drug undergoes extensive first pass extraction in the liver, and bioavailibity is low (< 5 %). Nanoparticles were prepared by modified ionotropic gelation method using 32 full factorial design. From the preliminary trials, the constraints for independent variables X1 (concentration of chitosan) and X2 (concentration of sodium tripolyphosphate) have been fixed and examined to investigate effect on particle size, encapsulation efficiency, zeta potential, % release, SEM, FTIR, XRD and DSC analysis of lovastatin. The diameter of prepared nanoparticles was controlled in the range of 100-800 nm, spherical shape and narrow diameter distribution. The release profiles of all batches were very well fitted by both the zero order model and the anomalous transport. These results indicate that lovastatin nanoparticles could be effective in sustaining drug release for a prolonged period.
引用
收藏
页码:1815 / 1823
页数:9
相关论文
共 30 条
  • [1] Freeze-drying of nanoparticles: Formulation, process and storage considerations
    Abdelwahed, Wassim
    Degobert, Ghania
    Stainmesse, Serge
    Fessi, Hatem
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2006, 58 (15) : 1688 - 1713
  • [2] Preparation, characterization and biodistribution of ultrafine chitosan nanoparticles
    Banerjee, T
    Mitra, S
    Singh, AK
    Sharma, RK
    Maitra, A
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 243 (1-2) : 93 - 105
  • [3] Barratt G., 1999, Pharm. Technol. Eur, V11, P25
  • [4] Studies on effect of pH on cross-linking of chitosan with sodium tripolyphosphate: A technical note
    Bhumkar, Devika R.
    Pokharkar, Varsha B.
    [J]. AAPS PHARMSCITECH, 2006, 7 (02)
  • [5] PREPARATION AND EVALUATION OF DRUG-CONTAINING CHITOSAN BEADS
    BODMEIER, R
    OH, KH
    PRAMAR, Y
    [J]. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1989, 15 (09) : 1475 - 1494
  • [6] Couvreur P., 2006, PHARM RES, V23, P284
  • [7] Preparation and characterization of nanocrystals for solubility and dissolution rate enhancement of nifedipine
    Hecq, J
    Deleers, M
    Fanara, D
    Vranckx, H
    Amighi, K
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2005, 299 (1-2) : 167 - 177
  • [8] Hirano H. S. S, 1990, PROGR BIOMEDICAL POL, P283
  • [9] Illum L, 1998, PHARM RES-DORDR, V15, P1326
  • [10] Chitosan nanoparticles as delivery systems for doxorubicin
    Janes, KA
    Fresneau, MP
    Marazuela, A
    Fabra, A
    Alonso, MJ
    [J]. JOURNAL OF CONTROLLED RELEASE, 2001, 73 (2-3) : 255 - 267